FILE PHOTO: Test tube with Coronavirus label is seen in this illustration
Its first phase, still ongoing, has focused on finding out how much of the virus is needed to trigger an infection while the second will aim to determine the immune response needed to ward one off, the university said in a statement on Tuesday. "This is the immune response we then need to induce with a new vaccine," said Helen McShane, Oxford University Professor of Vaccinology and the study's chief investigator.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Wanted: Volunteers to catch Covid-19 in the name of scienceThe world's first medical trial authorised to deliberately expose participants to the coronavirus is seeking more volunteers as it steps up efforts to help develop better vaccines. The Oxford University trial was launched last April, three months after Britain became the first country to approve what are known as challenge trials for humans involving Covid-19. Its first phase, still ongoing,...
Source: asiaonecom - 🏆 10. / 59 Read more »
Moderna starts trial testing Omicron-specific COVID-19 booster shotWASHINGTON: US biotech company Moderna announced on Wednesday (Jan 26) that it has begun clinical trials of a booster dose of vaccine designed specifically to combat the Omicron variant of the coronavirus. The trials will involve a total of 600 adults - half of whom have already received two doses of
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
China's Walvax says has most participants for large mRNA COVID-19 vaccine trialBEIJING: China\u0027s Walvax Biotechnology has recruited most of the 28,000 participants needed for a large clinical trial of its mRNA COVID-19 vaccine candidate, a senior company official said on Thursday (Jan 27). China has yet to approve a Chinese vaccine of the novel messenger RNA (mRNA) technology and has
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Pfizer and BioNTech launch trial of Omicron-targeted Covid-19 vaccineNEW YORK - Pfizer Inc and BioNTech SE said on Tuesday (Jan 25) they started a clinical trial to test a new version of their vaccine specifically designed to target the Covid-19 Omicron variant, which has eluded some of the protection provided by the original two-dose vaccine regimen. Banking on volunteers in the United States, the companies plan to test...
Source: asiaonecom - 🏆 10. / 59 Read more »
South Korea's daily new Covid-19 count exceeds 13,000 for first time
Source: STForeignDesk - 🏆 4. / 71 Read more »
South Korea's daily new COVID-19 case count exceeds 13,000 for first timeSEOUL: South Korea\u0027s daily new coronavirus cases exceeded 13,000 for the first time, data showed on Wednesday (Jan 26), while the government sought to revise its COVID-19 response to focus on the highly contagious but less-lethal Omicron variant. The record of 13,012 comes just a day after the tally
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »